| Financial Year |
March 31 2023 |
| Monetary Funds |
403,435,774.79 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
99,282,036.98 |
| Accounts Receivable |
232,713,829.80 |
| Advances to Suppliers |
22,350,765.24 |
| Other Receivables |
5,472,728.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
208,568,152.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,685,067.17 |
| Total Current Assets |
978,508,354.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
54,035,550.26 |
| Investment Properties |
-- |
| Fixed Assetes |
398,566,994.11 |
| Under-construction Projects |
36,786,640.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
16,905,896.17 |
| R&D expenses |
-- |
| Goodwill |
1,856,964.05 |
| Long-Term Deferred and Prepaid Expenses |
11,225,560.92 |
| Deferred Income Tax Assets |
14,169,379.17 |
| Other Non-Current Assets |
36,376,195.62 |
| Sub-Total of Non-Current Assets |
637,721,971.77 |
| Total Assets |
1,616,230,325.94 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
50,372,511.85 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,353,346.34 |
| Taxes Payable |
16,825,658.31 |
| Interest Payable |
-- |
| Dividend Payable |
11,600,000.00 |
| Other payables |
14,948,694.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,093,193.92 |
| Other Current Liabilities |
132,816.78 |
| Sub-Total of Current Liabilities |
112,276,977.94 |
| Long-term Loans |
1,265,682.03 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,602,962.75 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
30,603,490.37 |
| Total Liabilities |
142,880,468.31 |
| Paid-In Capital(Or Share Stock) |
427,500,000.00 |
| Capital Surplus |
67,309,044.85 |
| Surplus Reserve |
142,968,734.78 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
796,981,360.82 |
| Minority Stockholder's Interest |
38,590,717.18 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,434,759,140.45 |
| Owner's Equity（Stockholder's Equity） |
1,473,349,857.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,616,230,325.94 |
